A Review on Current Status of SARS‐CoV‐2 (2019‐nCoV): Its Diagnosis and Challenges | Chapter 19 | Highlights on Medicine and Medical Science Vol. 14

 The global Covid-19 pandemic is a huge source of concern because it affects everyone's life, whether directly or indirectly. Interpersonal and social interactions have changed dramatically as a result. According to the World Health Organization (W.H.O. ), there have been 140,886,773 confirmed cases of COVID-19, with 3,012,251 deaths. Of the total confirmed cases, only America has 59,757,984 cases, while India has 15,061,919 cases. Until April 18th, 2021, a total of 792,796,083 vaccination doses have been delivered worldwide. Infection and mortality among Health Care Workers (HCWs), as well as increased risk in vulnerable/susceptible groups, have all been important sources of concern. We've compiled a list of all the most recent updates on SARS-CoV-2 (2019-nCoV), covering epidemiology, clinical manifestations, laboratory diagnosis, vaccine development, preventive measures, and current and future problems.

Author (S) Details

Bhagat Singh
Department of Medical Lab. Technology, U P University of Medical Sciences, Saifai Etawah-206130, India.

Dheer Singh
Department of Anaesthesiology and Critical Care, U P University of Medical Sciences, Saifai, Etawah-206130, India.

Kamal Pant
Department of Optometry, U P University of Medical Sciences, Saifai, Etawah -206130, India.

Ramakant Yadav
Department of Neurology, UP University of Medical Sciences, Saifai, Etawah-206130, India.

Raj Kumar
Department of Neurosurgery, U P University of Medical Sciences, Saifai, Etawah -206130, India.

Rajesh Verma
Department of Microbiology, U P University of Medical Sciences, Saifai, Etawah-206130, India.

Renu Singh
Former Visiting Faculty, Microbiology, Faculty of Paramedical Sciences, UPUMS, Saifai, Etawah -206130, India.

Satender Saraswat
Department of Microbiology, U P University of Medical Sciences, Saifai, Etawah-206130, India.

View Book :- https://stm.bookpi.org/HMMS-V14/article/view/2570

Leptospirosis in Pigs: A Silent Economic Drawback in Piggery Industry | Chapter 2 | Research Aspects in Agriculture and Veterinary Sciences Vol. 1

 The epidemiology of Leptospirosis in pigs is discussed in this chapter. Leptospirosis is a zoonotic illness spread over the world caused by the genus Leptospira. The disease is endemic to tropical areas and affects both wild and domestic animals, as well as humans. Pigs from intensively confined, free-range, and feral environments can become infected if they come into direct or indirect contact with infected reservoir host animal urine. Leptospirosis in pigs manifests itself in a variety of ways, ranging from asymptomatic to chronic, depending on the infecting serovar and the age of the animals. Pig productivity loss is linked to chronic manifestations such as placentitis, abortions, stillbirths, infertility, and poor neonatal pigs. Culture, molecular technique, and serology are among the laboratory tests used to diagnose leptospirosis. Tetracyclines, dihydrostreptomycin, streptomycin, doxycycline, and erythromycin are examples of antibiotics that can be used to treat the condition. Vaccination, water sanitation, rodent control, and farm hygiene are all leptospirosis control measures.

Author (s) Details

Machunda Ndazi
Department of Biosciences, Sokoine University of Agriculture, P.O.Box 3038, Morogoro, Tanzania.

Beda John Mwang’onde
Department of Biosciences, Sokoine University of Agriculture, P.O.Box 3038, Morogoro, Tanzania.

View Book :- https://stm.bookpi.org/RAAVS-V1/article/view/2416